Respiratory syncytial virus (RSV) is a highly contagious seasonal lower respiratory tract infection (LRTI) and can be particularly dangerous for older adults, who experience more severe disease as a consequence of increased vulnerability to infection. Listen in as this multidisciplinary panel of experts discuss the disease burden of RSV in adults with a focus on hospitalizations, comorbidities, and related health disparities and the role of vaccines in prevention strategies.
Learning Objectives
At the conclusion of this activity, participants should be able to:
- Summarize the disease burden of RSV in U.S. adults, with a focus on hospitalizations, comorbidities, and related health disparities
- Assess the data for RSV vaccines to determine their potential role in prevention strategies for older adults
Acknowledgement of Commercial Support
This activity is supported by an educational grant from GSK.